Related Party Transactions

9 Months Ended

Sep. 30, 2020

Note 6. Related party transactions

BridgeBio Pharma LLC

BridgeBio through its ownership of BBP LLC, is a controlling stockholder in the Company, as it owned 63.7% and 64.6% of the Company’s total outstanding shares as of September 30, 2020 and December 31, 2019, respectively. In April 2016, the Company began receiving consulting, management, facility and infrastructure services pursuant to a services agreement with BBP LLC and the Company also provides similar services to BBP LLC and affiliates. The initial agreement was entered into on March 1, 2016 and was superseded by the subsequent agreement that was effective as of May 1, 2017.

The Company incurred the following (benefits) and expenses under the agreement with BBP LLC (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2020			2019			2020			2019
Rent	$	(40	)	$	(5	)	$	(84	)	$	(16	)
Facility		(2	)		(11	)		(46	)		64
Consulting		293			237			668			391
	$	251		$	221		$	538		$	439

As of September 30, 2020 and December 31, 2019, the Company had outstanding receivables from BBP LLC of $0.2 million and $0.1 million, respectively, related to providing services to other related companies of BBP LLC. As of September 30, 2020 and December 31, 2019, the Company had outstanding liabilities due to BBP LLC of $0.4 million and $0.3 million, respectively.

Eidos Therapeutics, Inc. 10-Q